Recombinant serotype 5 adenovirus (Ad5) vectors lacking E1 expression induce robust immune responses against encoded transgenes in pre-clinical models, but have muted responses in human trials because ...
As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and ...
WALTHAM, Mass.--(BUSINESS WIRE)--ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering transformative cell and gene therapies, today announced four poster presentations at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results